Effects of statin therapy on vascular dysfunction

被引:26
作者
Aikawa, M [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Excellence Vasc Biol Cardiovasc Med, Boston, MA 02115 USA
关键词
atherosclerosis; vascular biology; acute coronary syndromes; inflammation; oxidative stress; macrophages; endothelial cells; statin; HMG-CoA reductase inhibitor; plaque stabilization;
D O I
10.1097/01.mca.0000132583.04711.47
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dyslipidemia and vascular inflammation play critical roles in the onset of acute coronary syndromes including myocardial infarction. Recent advances in cardiovascular medicine demonstrate that lipid-lowering therapy by 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) prevents acute coronary complications, probably by limiting inflammation in atheroma. Although a number of studies have suggested various effects of statins on vascular dysfunction independent of lipid lowering, the clinical benefits of such effects are not established as yet. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 79 条
[1]   Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma [J].
Aikawa, M ;
Sugiyama, S ;
Hill, CC ;
Voglic, SJ ;
Rabkin, E ;
Fukumoto, Y ;
Schoen, FJ ;
Witztum, JL ;
Libby, P .
CIRCULATION, 2002, 106 (11) :1390-1396
[2]   The vulnerable atherosclerotic plaque - Pathogenesis and therapeutic approach [J].
Aikawa, M ;
Libby, P .
CARDIOVASCULAR PATHOLOGY, 2004, 13 (03) :125-138
[3]   Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma [J].
Aikawa, M ;
Rabkin, E ;
Voglic, SJ ;
Shing, H ;
Nagai, R ;
Schoen, FJ ;
Libby, P .
CIRCULATION RESEARCH, 1998, 83 (10) :1015-1026
[4]   Dietary lipid lowering reduces tissue factor expression in rabbit atheroma [J].
Aikawa, M ;
Voglic, SJ ;
Sugiyama, S ;
Rabkin, E ;
Taubman, MB ;
Fallon, JT ;
Libby, P .
CIRCULATION, 1999, 100 (11) :1215-1222
[5]   Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma - A potential mechanism of lesion stabilization [J].
Aikawa, M ;
Rabkin, E ;
Okada, Y ;
Voglic, SJ ;
Clinton, SK ;
Brinckerhoff, CE ;
Sukhova, GK ;
Libby, P .
CIRCULATION, 1998, 97 (24) :2433-2444
[6]  
Aikawa M, 2001, CIRCULATION, V103, P276
[7]   THE EFFECT OF CHOLESTEROL-LOWERING AND ANTIOXIDANT THERAPY ON ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION [J].
ANDERSON, TJ ;
MEREDITH, IT ;
YEUNG, AC ;
FREI, B ;
SELWYN, AP ;
GANZ, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) :488-493
[8]   Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia - A prospective, randomized, double-blind trial [J].
Ballantyne, CM ;
Houri, J ;
Notarbartolo, A ;
Melani, L ;
Lipka, LJ ;
Suresh, R ;
Sun, S ;
LeBeaut, AP ;
Sager, PT ;
Veltri, EP .
CIRCULATION, 2003, 107 (19) :2409-2415
[9]   HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J].
Bellosta, S ;
Via, D ;
Canavesi, M ;
Pfister, P ;
Fumagalli, R ;
Paoletti, R ;
Bernini, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (11) :1671-1678
[10]   C-reactive protein and other inflammatory risk markers in acute coronary syndromes [J].
Blake, GJ ;
Ridker, PM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (04) :37S-42S